Extracorporeal total artificial heart as bailout surgery

Stéphanie F Perrodin1, Olivier Muller2, Fabrizio Gronchi3

  • 1Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Journal of Cardiac Surgery
|February 16, 2017
PubMed

Insights

This study details using an extracorporeal heart with two ventricular assist devices to manage severe bleeding after a heart artery perforation. This "bailout" technique offers a potential solution for complex cardiac emergencies.

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Emergency Medicine

Background:

  • Uncontrolled bleeding after cardiac procedures poses a significant risk.
  • Proximal left anterior descending artery perforation is a rare but serious complication.
  • Novel techniques are needed to manage life-threatening hemorrhage during cardiac interventions.

Purpose of the Study:

  • To describe the application of a total extracorporeal heart.
  • To evaluate the use of two centrifugal ventricular assist devices as a bailout strategy.
  • To review existing literature on similar techniques and patient outcomes.

Main Methods:

  • Utilized a total extracorporeal heart system.
  • Employed two centrifugal ventricular assist devices (VADs) post-heart explantation.
  • Performed a comprehensive literature review of "bailout" techniques for uncontrolled bleeding.

Main Results:

  • Successfully managed uncontrolled bleeding using the described extracorporeal heart and VAD configuration.
  • The technique served as an effective "bailout" in a critical bleeding scenario.
  • Literature review provided context on the efficacy and challenges of similar approaches.

Conclusions:

  • The described extracorporeal heart and VAD strategy is a viable option for managing severe bleeding post-cardiac procedures.
  • This approach can be crucial in emergent situations involving left anterior descending artery perforation.
  • Further research and case studies are warranted to establish standardized protocols.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
490
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
300
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689